Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition

The Pathogenesis of Systemic Sclerosis

(2011) Tamiko R. Katsumoto et al.   Annual Review of Pathology-Mechanisms of Disease

Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae

(2011) F. Margheri et al.   BLOOD

Possible strategies for anti-fibrotic drug intervention in scleroderma

(2011) Andrew Leask   Journal of Cell Communication and Signaling

Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12

(2010) Francesca Margheri et al.   ARTHRITIS AND RHEUMATISM

EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style

(2009) M. Parri et al.   CANCER RESEARCH

Noncanonical transforming growth factor β signaling in scleroderma fibrosis

(2009) Maria Trojanowska   CURRENT OPINION IN RHEUMATOLOGY

Fibroblast activation and myofibroblast generation in obstructive nephropathy

(2009) María T. Grande et al.   Nature Reviews Nephrology

TGFβ1 antagonistic peptides inhibit TGFβ1-dependent angiogenesis

(2008) Simona Serratì et al.   BIOCHEMICAL PHARMACOLOGY

Non-Smad pathways in TGF-β signaling

(2008) Ying E Zhang   CELL RESEARCH

Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis

(2008) Xu Shi-Wen et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?

(2008) D. Abraham   RHEUMATOLOGY